在生命周期背景下的新生儿筛查随访：密歇根州的经验。

Newborn screening follow-up within the lifespan context: Michigan's experience.

机构信息

Division of Genomics, Perinatal Health and Chronic Disease Epidemiology, Michigan Department of Community Health, Lansing, MI 48909, USA.

出版信息

Am J Prev Med. 2010 Apr;38(4 Suppl):S522-7. doi: 10.1016/j.amepre.2010.01.002.

DOI:10.1016/j.amepre.2010.01.002

PMID:20331953

Abstract

Experience in using various data sources for surveillance systems and studies complements the growing knowledge base regarding requirements for newborn screening follow-up, which include integration with services other than clinical subspecialties. A proposed model for utilizing state resources to develop sickle cell disease surveillance across the lifespan is presented. This surveillance process should help evaluate the burden of sickle cell disease across the lifespan, and it could be used as a model for other hemoglobinopathies as well as other newborn screening disorders. Through the continued assessment and monitoring of prevalence, comorbidities, service utilization, cost, and patient outcomes, the newborn screening follow-up program will be able to inform public health policy.

摘要

利用各种数据源进行监测系统和研究的经验补充了不断增长的关于新生儿筛查随访要求的知识库，其中包括与临床专科以外的服务相结合。提出了一个利用州资源在整个生命周期内开发镰状细胞病监测的模型。这个监测过程应该有助于评估整个生命周期内镰状细胞病的负担，也可以作为其他血红蛋白病以及其他新生儿筛查疾病的模型。通过对患病率、合并症、服务利用、成本和患者结果的持续评估和监测，新生儿筛查随访计划将能够为公共卫生政策提供信息。